PPB - Services

Complaints, Feedback and Enquiry

Pharmacovigilance July-September 2023/2024 Q1 Report

[featured_image]
  • Version
  • Download 394
  • File Size 942.82 KB
  • File Count 1
  • Create Date November 20, 2023
  • Last Updated November 20, 2023

Pharmacovigilance July-September 2023/2024 Q1 Report

The Pharmacy and Poisons Board is the National Regulatory Authority established under the Pharmacy and Poisons Act, Chapter 244 of the Laws of Kenya. The Board regulates the Practice of Pharmacy and the manufacture and trade of drugs and poisons. PPB has 4 directorates and the directorate of product safety (PDS) is responsible for Pharmacovigilance, Post-Market Surveillance, Clinical Trials & Medicines Information activities. PDS shares quarterly pharmacovigilance reports with stakeholders to serve as a feedback mechanism and also encourage all stakeholders to report. Since the introduction of PV in Kenya, a total of 16,698 individual case safety reports have been submitted to the global data reports 36,447,123 (0.05%).

Attached Files

FileAction
PHARMACOVIGILANCE Q1 SUMMARY 2023:2024.pdfDownload

Author

Tony Kemboi

Leave a comment

Your email address will not be published. Required fields are marked *